0001209191-23-035862.txt : 20230609
0001209191-23-035862.hdr.sgml : 20230609
20230609162647
ACCESSION NUMBER: 0001209191-23-035862
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rubinstein Linda M
CENTRAL INDEX KEY: 0001321937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36579
FILM NUMBER: 231005677
MAIL ADDRESS:
STREET 1: 25861 INDUSTRIAL BLVD
CITY: HAYWARD
STATE: CA
ZIP: 94545
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adverum Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001501756
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205258327
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: (650) 649-1004
MAIL ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Avalanche Biotechnologies, Inc.
DATE OF NAME CHANGE: 20100921
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-07
0
0001501756
Adverum Biotechnologies, Inc.
ADVM
0001321937
Rubinstein Linda M
C/O ADVERUM BIOTECHNOLOGIES, INC.
100 CARDINAL WAY
REDWOOD CITY
CA
94063
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-06-07
4
P
0
100000
1.4549
A
100000
D
Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.38 to $1.53. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Linda Rubinstein, by /s/ Ron A. Metzger, Attorney-in-Fact
2023-06-09